BioCentury
ARTICLE | Company News

Target ALS and partners launch biomarker study

April 20, 2018 7:09 PM UTC

Target ALS Foundation (New York, N.Y.) is partnering with the Muscular Dystrophy Association (MDA) (Chicago, Ill.), the CReATe Consortium and 10 industry partners to conduct a study to validate biomarker candidates for amyotrophic lateral sclerosis.

The study will seek to validate previously identified ALS biomarkers by measuring levels in patient samples and analyzing clinical information from the CReATe Consortium (Clinical Research in ALS and Related Disorders for Therapeutic Development). Data and analysis from the study will be made available to ALS researchers with the goal of using the biomarkers in current and future clinical trials...